Abstract:Large synthetic genetic circuits require the simultaneous expression of many regulators. Deactivated Cas9 (dCas9) can serve as a repressor by having a small guide RNA (sgRNA) direct it to bind a promoter. The programmability and specificity of RNA:DNA basepairing simplifies the generation of many orthogonal sgRNAs that, in theory, could serve as a large set of regulators in a circuit. However, dCas9 is toxic in many bacteria, thus limiting how high it can be expressed, and low concentrations are quickly sequestered by multiple sgRNAs. Here, we construct a non-toxic version of dCas9 by eliminating PAM (protospacer adjacent motif) binding with a R1335K mutation (dCas9*) and recovering DNA binding by fusing it to the PhlF repressor (dCas9*_PhlF). Both the 30 bp PhlF operator and 20 bp sgRNA binding site are required to repress a promoter. The larger region required for recognition mitigates toxicity in Escherichia coli, allowing up to 9600 ± 800 molecules of dCas9*_PhlF per cell before growth or morphology are impacted, as compared to 530 ± 40 molecules of dCas9. Further, PhlF multimerization leads to an increase in average cooperativity from n = 0.9 (dCas9) to 1.6 (dCas9*_PhlF). A set of 30 orthogonal sgRNA-promoter pairs are characterized as NOT gates; however, the simultaneous use of multiple sgRNAs leads to a monotonic decline in repression and after 15 are co-expressed the dynamic range is <10-fold. This work introduces a non-toxic variant of dCas9, critical for its use in applications in metabolic engineering and synthetic biology, and exposes a limitation in the number of regulators that can be used in one cell when they rely on a shared resource.

Integration and Exchange of Split Dcas9 Domains for Transcriptional Controls in Mammalian Cells

Programmable Transcriptional Modulation with a Structured RNA-Mediated CRISPR-dCas9 Complex

Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system

Split Cas9, Not Hairs - Advancing the Therapeutic Index of CRISPR Technology

Establishing Artificial Gene Connections Through RNA Displacement–assembly-Controlled CRISPR/Cas9 Function

Rational Design of Mini-Cas9 for Transcriptional Activation

Multiplexed activation in mammalian cells using a split-intein CRISPR/Cas12a based synthetic transcription factor

Cas9-Based Tools For Targeted Genome Editing And Transcriptional Control

Programmable mammalian translational modulators by CRISPR-associated proteins

Inducible CRISPR-dCas9 Transcriptional Systems for Sensing and Genome Regulation.

Complex transcriptional modulation with orthogonal and inducible dCas9 regulators

Engineered Dcas9 with Reduced Toxicity in Bacteria: Implications for Genetic Circuit Design

Orthogonal inducible control of Cas13 circuits enables programmable RNA regulation in mammalian cells

Engineered CRISPRa System for Precise and Multiplex Gene Regulation Using a Hybrid Dcas12a Variant and Hairpin-Spacer Crrnas.

Multiplexed Genome Regulation in Vivo with Hyper-Efficient Cas12a

A synthetic transcription platform for programmable gene expression in mammalian cells

Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector

CRISPR/dCas9 Tools: Epigenetic Mechanism and Application in Gene Transcriptional Regulation

Multiplex gene regulation by CRISPR-ddCpf1

Characteristics, Recombination Methods, and Applications Progresses of Split-Cas9 System.

CRISPR–Cas-mediated transcriptional control and epi-mutagenesis